Skip to main content
Luye Pharma Group Limited logo

Luye Pharma Group Limited — Investor Relations & Filings

Ticker · 2186 HKEX Manufacturing
Open in API
Filings indexed 1,503 across all filing types
Latest filing 2025-07-22 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 2186

About Luye Pharma Group Limited

http://www.luye.cn

Luye Pharma Group is an international pharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative medications, novel formulations, and biopharmaceutical products. The company's core strategy emphasizes advanced drug delivery systems, including microspheres, liposomes, and transdermal technologies, to enhance therapeutic efficacy and patient compliance. Luye Pharma maintains a strong focus on key therapeutic areas, particularly the Central Nervous System (CNS). Its portfolio includes proprietary products such as Roxinlin® (Toludesvenlafaxine extended-release tablets) and various long-acting injectable antipsychotic formulations, positioning the group as a global pharmaceutical enterprise.

Recent filings

Filing Released Lang Actions
Notification Letter and Reply Form to Registered Shareholders
Report Publication Announcement Classification · 95% confidence The document is a “Notification Letter” informing shareholders that the company’s Annual Report 2024/25, related circular, notice of AGM and proxy form (“Current Corporate Communication”) have been published on the company and exchange websites and providing instructions on how to request printed copies. It does not contain the full Annual Report or the circular content itself but simply announces their availability. Under the “menu vs meal” rule, this is an announcement of report publication rather than the report, circular, or proxy materials themselves. Therefore it is classified as a Report Publication Announcement (RPA).
2025-07-22 English
Form of proxy for use by shareholders at the Annual General Meeting to be convened on Friday, 15 August 2025 at 10:00 a.m.
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a Form of Proxy sent to shareholders ahead of an Annual General Meeting, listing resolutions and voting instructions. This is part of the proxy solicitation process, matching the definition for Proxy Solicitation & Information Statement (PSI).
2025-07-22 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 90% confidence The document is the formal notice convening the Annual General Meeting, detailing resolutions to be voted on and proxy arrangements. This is not the AGM presentation itself (AGM-R) nor a simple regulatory announcement (RNS) but rather materials sent to shareholders to provide information and request votes for the meeting. This matches Proxy Solicitation & Information Statement (PSI).
2025-07-22 English
GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; RE-ELECTION OF DIRECTORS&#x3b; RE-APPOINTMENT OF INDEPENDENT AUDITOR&#x3b; AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a shareholder circular for an upcoming Annual General Meeting. It includes detailed proxy materials: explanations of resolutions (share issue and repurchase mandates, re-election of directors, auditor appointment), explanatory statements, appendices and the formal notice of the AGM with instructions for proxy voting. This matches the definition of a Proxy Solicitation & Information Statement (materials sent to shareholders to provide information and request votes for meetings).
2025-07-22 English
Terms of Reference for the Nomination Committee (amended and adopted by the Board on 17 July 2025)
Governance Information Classification · 92% confidence The document is the Terms of Reference for the Nomination Committee, detailing membership, duties, meeting procedures, reporting responsibilities, and governance policies under the company’s board charters. It is not an announcement of a change or an external report, but an internal governance charter. This fits the Governance Information category.
2025-07-17 English
SUPPLEMENTAL ANNOUNCEMENT - APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Board/Management Information Classification · 85% confidence The document is a supplemental announcement concerning the appointment of an independent non-executive director, elaborating on independence criteria and confirming no change to other disclosed information. This is clearly an announcement of a change in the company's board of directors, fitting the Board/Management Information category.
2025-07-16 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.